Zotefoams plc (LON:ZTF – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 450.05 ($6.01) and traded as low as GBX 426 ($5.69). Zotefoams shares last traded at GBX 426 ($5.69), with a volume of 28,917 shares trading hands.
Zotefoams Stock Down 2.1 %
The firm’s 50-day moving average is GBX 469.42 and its 200 day moving average is GBX 450.05. The company has a debt-to-equity ratio of 43.67, a quick ratio of 0.67 and a current ratio of 1.30. The firm has a market capitalization of £207.04 million, a P/E ratio of 2,130.00, a PEG ratio of 0.66 and a beta of 1.40.
Zotefoams Cuts Dividend
The firm also recently declared a dividend, which will be paid on Monday, October 7th. Shareholders of record on Thursday, September 5th will be given a dividend of GBX 2.38 ($0.03) per share. The ex-dividend date of this dividend is Thursday, September 5th. This represents a yield of 0.48%. Zotefoams’s dividend payout ratio (DPR) is presently 3,500.00%.
About Zotefoams
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Recommended Stories
- Five stocks we like better than Zotefoams
- How to Invest in Biotech Stocks
- The Average 401k Balance by Age Explained
- How to Invest in Small Cap Stocks
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What Are Dividend Contenders? Investing in Dividend Contenders
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Zotefoams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zotefoams and related companies with MarketBeat.com's FREE daily email newsletter.